https://time.com/7086622/depression-treatment-app-rejoyn/
The U.S. Food and Drug Administration cleared the first app-based treatment for major depressive disorder, which just became available for use this summer.
The app, called Rejoyn, is cleared as a supplement to currently approved therapies and works by using specifically designed tasks on a smartphone app to rewire neural signals. The idea is to tap into the brain’s circuits so depressive signals and pathways don’t spiral into the debilitating emotional episodes typical of clinical depression.
No comments :
Post a Comment
ANONYMOUS COMMENTS WILL NOT BE POSTED!
please use either your real name or a pseudonym.